Major cardiovascular complications (cardiovascular death, non‐fatal myocardial infarction, non‐fatal stroke, and non‐fatal cardiac arrest) · adults undergoing surgery

Active body surface warming systems showed no clear difference in major cardiovascular complications (cardiovascular death, non‐fatal… compared with control (low certainty).

1 finding from 1 review

Active body surface warming systems for preventing complications caused by inadvertent perioperative hypothermia in… 2016 · Cochrane Headline outcomes only
RR 0.22 [0.05, 1]
1 study · 300 participants
Low

Active body surface warming systems vs control

All‐cause mortality · adults undergoing surgery

Active body surface warming systems showed no clear difference in all‐cause mortality compared with control (low certainty).

1 finding from 1 review

Active body surface warming systems for preventing complications caused by inadvertent perioperative hypothermia in… 2016 · Cochrane Headline outcomes only
RR 1.01 [0.26, 4]
2 studies · 500 participants
Low

Active body surface warming systems vs control

Number of patients transfused ( · adults undergoing surgery

Active body surface warming systems showed no clear difference in participants transfused compared with control (moderate certainty).

1 finding from 1 review

Active body surface warming systems for preventing complications caused by inadvertent perioperative hypothermia in… 2016 · Cochrane Headline outcomes only
RR 0.79 [0.5, 1.23]
8 studies · 621 participants
Moderate

Active body surface warming systems vs control

Shivering · adults undergoing surgery

Active body surface warming systems leads to lower chills/shivering compared with control (high certainty).

1 finding from 1 review

Active body surface warming systems for preventing complications caused by inadvertent perioperative hypothermia in… 2016 · Cochrane Headline outcomes only
RR 0
29 studies · 1922 participants
High

ACTIVA bioactive restorative material vs Glass ionomer cement (GIC)

Secondary caries · Patients requiring dental restoration; permanent teeth

Over 1 year in permanent teeth, the effect of ACTIVA versus GIC on secondary caries is very uncertain (RR 22.80, 95% CI 0.89-584.17; very low certainty).

1 finding from 1 review

Clinical efficacy of bioactive restorative materials in controlling secondary caries: a systematic review and network… 2023 All outcomes
1 year of follow-up · Restorative dentistry clinical settings; primary studies conducted across multiple countries
RR 22.80 [0.89, 584.17]
1 study · 153 participants
Very low

Higher JIA disease activity/severity (e.g., high JADAS/activity scores, polyarticular RF-negative subtype, active disease, anti-TNFalpha or cyclosporine medication) vs Lower JIA disease activity / inactive or milder JIA

Prevalence and severity of oral and TMJ diseases/conditions (periodontal status and dental caries) · Children and adolescents with juvenile idiopathic arthritis (JIA)

Some studies suggested greater JIA disease activity/severity (and certain medications) was associated with worse periodontal and caries outcomes, but small samples meant no solid conclusion could be drawn (ungraded).

1 finding from 1 review

Oral health in children and adolescents with juvenile idiopathic arthritis - a systematic review and meta-analysis. 2019 All outcomes
Multiple countries (Brazil, Sweden, Germany); paediatric rheumatology/dental settings
Higher JIA disease activity/severity was associated with worse oral outcomes in several studies: JADAS and global activity scores correlated positively with DMFT and gingival indices [27]; a polyarticular RF-negative…
Studies not reported
GRADE not reported

Alternating pressure (active) air surfaces vs foam surfaces

Proportion of participants developing a new pressure ulcer · pressure ulcer prevention

Alternating pressure (active) air surfaces showed no clear difference in proportion of participants developing a new pressure ulcer compared with foam surfaces (low certainty).

1 finding from 1 review

Alternating pressure (active) air surfaces for preventing pressure ulcers 2021 · Cochrane Headline outcomes only
RR 0.63 [0.34, 1.17]
4 studies · 2247 participants
Low

Alternating pressure (active) air surfaces vs foam surfaces

Time to pressure ulcer development · pressure ulcer prevention

It is very uncertain whether alternating pressure (active) air surfaces changes time to pressure ulcer development compared with foam surfaces (very low certainty).

1 finding from 1 review

Alternating pressure (active) air surfaces for preventing pressure ulcers 2021 · Cochrane Headline outcomes only
HR 0.41 [0.1, 1.64]
2 studies · 2105 participants
Very low

Alternating pressure (active) air surfaces vs foam surfaces

Support surface associated patient comfort · pressure ulcer prevention

1 finding from 1 review

Alternating pressure (active) air surfaces for preventing pressure ulcers 2021 · Cochrane Headline outcomes only
no estimate extracted
1 study · 76 participants
Very low

Alternating pressure (active) air surfaces vs foam surfaces

All reported adverse events · pressure ulcer prevention

1 finding from 1 review

Alternating pressure (active) air surfaces for preventing pressure ulcers 2021 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 2181 participants
Very low

Alternating pressure (active) air surfaces vs foam surfaces

QoL · pressure ulcer prevention

2 findings from 1 review

Alternating pressure (active) air surfaces for preventing pressure ulcers 2021 · Cochrane Headline outcomes only
no estimate extracted
1 study · 267 participants
Low
Alternating pressure (active) air surfaces for preventing pressure ulcers 2021 · Cochrane Headline outcomes only
no estimate extracted
1 study · 233 participants
Low

Alternating pressure (active) air surfaces vs foam surfaces

Cost‐effectiveness · pressure ulcer prevention

1 finding from 1 review

Alternating pressure (active) air surfaces for preventing pressure ulcers 2021 · Cochrane Headline outcomes only
no estimate extracted
1 study · 1 participants
Moderate

Active treatment vs observation

Eradication of MRSA · adults or children with positive microbiological isolate of MRSA from a respiratory tract specimen

Active treatment showed no clear difference in eradication of MRSA: number of participants that were MRSA‐negativea compared with observation only (low certainty).

1 finding from 1 review

Interventions for the eradication of meticillin‐resistant Staphylococcus aureus (MRSA) in people with cystic fibrosis 2022 · Cochrane Headline outcomes only
OR 1.72 [0.65, 4.55]
2 studies · 68 participants
Low

Active treatment vs observation

Time until next positive MRSA isolate (from clinically relevant respiratory culture) · adults or children with positive microbiological isolate of MRSA from a respiratory tract specimen

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for the eradication of meticillin‐resistant Staphylococcus aureus (MRSA) in people with cystic fibrosis 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Active treatment vs observation

Quality of life: CFRSD‐CRISS symptom score · adults or children with positive microbiological isolate of MRSA from a respiratory tract specimen

1 finding from 1 review

Interventions for the eradication of meticillin‐resistant Staphylococcus aureus (MRSA) in people with cystic fibrosis 2022 · Cochrane Headline outcomes only
no estimate extracted
1 study · 45 participants
Low

Active treatment vs observation

FEV1 % predicted: absolute change from baseline · adults or children with positive microbiological isolate of MRSA from a respiratory tract specimen

1 finding from 1 review

Interventions for the eradication of meticillin‐resistant Staphylococcus aureus (MRSA) in people with cystic fibrosis 2022 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 58 participants
Very low

Active treatment vs observation

Change in weight (kg) · adults or children with positive microbiological isolate of MRSA from a respiratory tract specimen

1 finding from 1 review

Interventions for the eradication of meticillin‐resistant Staphylococcus aureus (MRSA) in people with cystic fibrosis 2022 · Cochrane Headline outcomes only
no estimate extracted
1 study · 38 participants
Very low